Astec LifeSciences Limited (NSE:ASTEC)
India
· Delayed Price · Currency is INR 702.75
-24.00 (-3.30%)
Apr 29, 2026, 3:25 PM IST
Astec LifeSciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Operating Revenue | 4,481 | 3,781 | 4,577 | 6,282 | 6,766 | Upgrade
|
| Other Revenue | 50.71 | 31.57 | 9.41 | 3.31 | 3.34 | Upgrade
|
| Revenue | 4,532 | 3,813 | 4,586 | 6,285 | 6,769 | Upgrade
|
| Revenue Growth (YoY) | 18.86% | -16.86% | -27.03% | -7.15% | 21.16% | Upgrade
|
| Cost of Revenue | 2,984 | 3,056 | 3,249 | 4,069 | 3,920 | Upgrade
|
| Gross Profit | 1,548 | 757.2 | 1,338 | 2,216 | 2,849 | Upgrade
|
| Selling, General & Admin | 629.08 | 621.68 | 629 | 533.27 | 513.32 | Upgrade
|
| Other Operating Expenses | 913.49 | 797.59 | 762.03 | 911.8 | 788.77 | Upgrade
|
| Operating Expenses | 1,992 | 1,856 | 1,754 | 1,782 | 1,646 | Upgrade
|
| Operating Income | -443.77 | -1,099 | -415.94 | 434.56 | 1,203 | Upgrade
|
| Interest Expense | -345.29 | -362.76 | -248.56 | -201.58 | -86.95 | Upgrade
|
| Interest & Investment Income | - | 8.03 | 1.51 | 40.49 | 2.63 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 15.9 | 49.71 | 83.92 | 72.45 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 1.74 | -3.09 | -3.85 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | -789.06 | -1,436 | -616.37 | 353.54 | 1,191 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 20.18 | -1.11 | -5.24 | 0.14 | Upgrade
|
| Other Unusual Items | -20.94 | - | - | - | - | Upgrade
|
| Pretax Income | -810 | -1,410 | -617.48 | 349.47 | 1,211 | Upgrade
|
| Income Tax Expense | -1.24 | -62.78 | -148.57 | 93.53 | 312.43 | Upgrade
|
| Earnings From Continuing Operations | -808.76 | -1,347 | -468.91 | 255.94 | 898.83 | Upgrade
|
| Minority Interest in Earnings | -0.41 | -0.41 | -0.39 | -0.29 | -0.24 | Upgrade
|
| Net Income | -809.18 | -1,348 | -469.3 | 255.65 | 898.59 | Upgrade
|
| Net Income to Common | -809.18 | -1,348 | -469.3 | 255.65 | 898.59 | Upgrade
|
| Net Income Growth | - | - | - | -71.55% | 38.14% | Upgrade
|
| Shares Outstanding (Basic) | 21 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Change (YoY) | 9.18% | 0.01% | 0.02% | 0.04% | 0.05% | Upgrade
|
| EPS (Basic) | -37.79 | -68.71 | -23.93 | 13.04 | 45.87 | Upgrade
|
| EPS (Diluted) | -37.79 | -68.71 | -23.93 | 13.04 | 45.85 | Upgrade
|
| EPS Growth | - | - | - | -71.56% | 38.06% | Upgrade
|
| Free Cash Flow | -862.44 | -302.21 | -1,253 | -426.03 | -803.74 | Upgrade
|
| Free Cash Flow Per Share | -40.28 | -15.41 | -63.88 | -21.73 | -41.01 | Upgrade
|
| Dividend Per Share | - | - | 1.500 | 1.500 | 1.500 | Upgrade
|
| Gross Margin | 34.16% | 19.86% | 29.17% | 35.26% | 42.09% | Upgrade
|
| Operating Margin | -9.79% | -28.83% | -9.07% | 6.91% | 17.78% | Upgrade
|
| Profit Margin | -17.85% | -35.34% | -10.23% | 4.07% | 13.28% | Upgrade
|
| Free Cash Flow Margin | -19.03% | -7.93% | -27.32% | -6.78% | -11.87% | Upgrade
|
| EBITDA | 5.45 | -670.07 | -61.53 | 759.35 | 1,536 | Upgrade
|
| EBITDA Margin | 0.12% | -17.57% | -1.34% | 12.08% | 22.70% | Upgrade
|
| D&A For EBITDA | 449.22 | 429.14 | 354.41 | 324.79 | 332.88 | Upgrade
|
| EBIT | -443.77 | -1,099 | -415.94 | 434.56 | 1,203 | Upgrade
|
| EBIT Margin | -9.79% | -28.83% | -9.07% | 6.91% | 17.78% | Upgrade
|
| Effective Tax Rate | - | - | - | 26.76% | 25.79% | Upgrade
|
| Revenue as Reported | 4,532 | 3,869 | 4,638 | 6,412 | 6,870 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.